Optic Neuritis Not Yet Recruiting Phase 0 Trials for Dalfampridine (DB06637)

Also known as: Optical Neuritis / Unspecified optic neuritis / Optic neuritis NOS / Optic neuritis, unspecified / Neuritis optic

IndicationStatusPhase
DBCOND0027863 (Optic Neuritis)Not Yet Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04148781Fampridine-SR and Optic Neuritis RecoveryTreatment